Congenital Hyperinsulinism International
AMIDEBIO CTO Dr. Michael Stowell will present a talk titled “Novel Pumpable Glucagons for Treating Hyperinsulinism” at the 2017 International Congenital Hyperinsulinism Conference July 15-16.
AMIDEBIO granted E.U. Patent No. 2,787,083